Adjunctive therapy (whole body hyperthermia versus lonidamine) to total body irradiation for the treatment of favorable b-cell neoplasms: a report of two pilot clinical trials and laboratory investigations
- 1 April 1990
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 18 (4) , 909-920
- https://doi.org/10.1016/0360-3016(90)90416-h
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Potentiation of differential hyperthermic sensitivity of AKR leukemia and normal bone marrow cells by lidocaine or thiopentalCancer, 1984
- Inhibition of the recovery from potentially lethal damage by lonidamineBritish Journal of Cancer, 1984
- Radiosensitization of Meth-A Fibrosarcoma in Mice by LonidamineOncology, 1984
- Lonidamine and Radiotherapy in Head and Neck CancersOncology, 1984
- Pharmacokinetics of Lonidamine after Oral Administration in Cancer PatientsOncology, 1984
- Lonidamine: A Hyperthermic Sensitizer of HeLa Cells in Culture and of the Meth-A Tumor in vivoOncology, 1984
- Radiosensitization of hematopoietic precursor cells (CFUc) in glioblastoma patients receiving intermittent intravenous infusions of bromodeoxyuridine (BUdR)International Journal of Radiation Oncology*Biology*Physics, 1983
- A Confidence Interval for the Median Survival TimePublished by JSTOR ,1982
- Treatment of chronic lymphocytic leukemia by total body irradiation alone and combined with chemotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1979
- Treatment of chronic lymphocytic leukemia with emphasis on total body irradiationInternational Journal of Radiation Oncology*Biology*Physics, 1976